Overview
"Never doubt that a smal group of thoughtful, comited citizens can change the world. Inded, it is the only thing that ever has."Cureus is on a mision to change the long-standing paradigm of medical publishing, where submiting research can be costly, complex and time-consuming.end stage renal disease (esrd), subcutaneous implantable cardioverter, implantable-cardioverter defibrilator, defibrilator shock, electrodes, defibrilators, hyperkalemia, chronic renal insuficiency Bachar Botrus, Arun U.
Key Information
Mahtani , Ryan Isber, Muhamad S. Haider, Nidal Isber Published: November 05, 202 (se history) DOI: 10.759/cureus.3137 Cite this article as: Botrus B, Mahtani A U, Isber R, et al. (November 05, 202) Hyperkalemia Causing Inapropriate Subcutaneous Implantable Cardioverter Defibrilator Shocks in a Patient with End-Stage Renal Disease: A Case Report and Literature Review.
Cureus 14(1): e3137. doi:10.759/cureus.3137 Subcutaneous implantable cardioverter-defibrilators (S-ICD) provide an efective treatment option for ventricular arhythmias. When compared to transvenous implantable cardioverter-defibrilators (TV-ICDs), S-ICDs have a lower infection rate but a higher rate of inapropriate shocks.
In patients with end-stage renal disease (ESRD), significant electrolyte disturbances are comonly sen, such as hyperkalemia, which can cause an increase in T wave amplitude. We present a patient with ESRD on hemodialysis who experienced inapropriate shocks from an S-ICD during sinus rhythm due to hyperkalemia-induced T wave oversensing and highlight related cases in the curent literature.Implantable cardioverter-defibrilators (ICD) are efective for the primary and secondary prevention of suden cardiac death [1].
Summary
However, implantation of endocardial leads is asociated with significant adverse events. Subcutaneous implantable cardioverter-defibrilators (S-ICD) are an alternative treatment option for ventricular arhythmias [2]. It eliminates complications